GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bioscience Animal Health PCL (BKK:BIS) » Definitions » Equity-to-Asset

Bioscience Animal Health PCL (BKK:BIS) Equity-to-Asset : 0.69 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Bioscience Animal Health PCL Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Bioscience Animal Health PCL's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ฿789 Mil. Bioscience Animal Health PCL's Total Assets for the quarter that ended in Mar. 2024 was ฿1,146 Mil. Therefore, Bioscience Animal Health PCL's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.69.

The historical rank and industry rank for Bioscience Animal Health PCL's Equity-to-Asset or its related term are showing as below:

BKK:BIS' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.13   Med: 0.65   Max: 0.7
Current: 0.69

During the past 7 years, the highest Equity to Asset Ratio of Bioscience Animal Health PCL was 0.70. The lowest was 0.13. And the median was 0.65.

BKK:BIS's Equity-to-Asset is ranked better than
72.42% of 1925 companies
in the Consumer Packaged Goods industry
Industry Median: 0.54 vs BKK:BIS: 0.69

Bioscience Animal Health PCL Equity-to-Asset Historical Data

The historical data trend for Bioscience Animal Health PCL's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioscience Animal Health PCL Equity-to-Asset Chart

Bioscience Animal Health PCL Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.13 0.26 0.29 0.70 0.64

Bioscience Animal Health PCL Quarterly Data
Dec17 Dec18 Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 0.67 0.65 0.64 0.69

Competitive Comparison of Bioscience Animal Health PCL's Equity-to-Asset

For the Packaged Foods subindustry, Bioscience Animal Health PCL's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioscience Animal Health PCL's Equity-to-Asset Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Bioscience Animal Health PCL's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Bioscience Animal Health PCL's Equity-to-Asset falls into.



Bioscience Animal Health PCL Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Bioscience Animal Health PCL's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=779.846/1228.092
=0.64

Bioscience Animal Health PCL's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=789.092/1146.2
=0.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioscience Animal Health PCL  (BKK:BIS) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Bioscience Animal Health PCL Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Bioscience Animal Health PCL's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioscience Animal Health PCL (BKK:BIS) Business Description

Traded in Other Exchanges
N/A
Address
Bond Street Road, No. 479, 4th Floor, Muangthongthani, Bangphut, Pakkret, Nonthaburi, THA, 11120
Bioscience Animal Health PCL engaged in manufacture, import and distribution of pharmaceutical supplies, medical devices, equipment, and products for livestock and companion animals (pets). Geographically, the company generates revenue from Thailand.

Bioscience Animal Health PCL (BKK:BIS) Headlines